CABAZITAXEL EVER PHARMA cabazitaxel 45 mg/4.5 mL concentrated solution for injection vial

Produktübersicht

About CABAZITAXEL EVER PHARMA cabazitaxel

CABAZITAXEL EVER PHARMA cabazitaxel is a medication containing the active ingredient cabazitaxel. Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE JEVTANA ® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

cabazitaxel, the active ingredient in CABAZITAXEL EVER PHARMA cabazitaxel, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE JEVTANA ® is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking CABAZITAXEL EVER PHARMA cabazitaxel. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use CABAZITAXEL EVER PHARMA cabazitaxel for extended periods without medical advice.